# Prediction of Everolimus-induced Interstitial Lung Disease

> **NCT01978171** · — · COMPLETED · sponsor: **Radboud University Medical Center** · enrollment: 27 (actual)

## Conditions studied

- Breast Neoplasms

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01978171
- **Lead sponsor:** Radboud University Medical Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2014-05
- **Primary completion:** 2018-01-15
- **Final completion:** 2018-01-15
- **Target enrollment:** 27 (ACTUAL)
- **Last updated:** 2018-04-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01978171

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01978171, "Prediction of Everolimus-induced Interstitial Lung Disease". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01978171. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*